Literature DB >> 20685284

Protective effect of beta-casomorphin-7 on type 1 diabetes rats induced with streptozotocin.

Hong Yin1, Jinfeng Miao, Yuanshu Zhang.   

Abstract

The present study was aimed to investigate the possible effects of beta-casomorphin-7, against hyperglycemia and free radical-mediated oxidative stress in streptozotocin-induced diabetic rats by assaying the blood glucose level and the activity of plasma enzymatic antioxidants, such as superoxide dismutase (SOD), catalase and glutathione peroxidase (GSH-Px). A significant increase in the levels of both blood glucose and oxidative stress with a predominant decrease in antioxidant status was observed in the diabetic rats when compared to control rats. After 15 days oral administration of beta-casomorphin-7 (7.5 x 10(-8) mol/day), the elevated blood glucose level was reduced. Oral administration of beta-CM-7 to diabetic rats showed an increase in the level of plasma insulin, the elevated plasma glucagon level was markedly reduced by the oral administration of beta-CM-7. Oral administration of beta-CM-7 to the diabetic group of rats also showed a significant elevation in the activity of SOD and catalase. Thus, the results of the present study suggest that beta-casomorphin-7 can protect rats from hyperglycemia and free radical-mediated oxidative stress in diabetic rats. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20685284     DOI: 10.1016/j.peptides.2010.05.016

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  8 in total

1.  Immunohistochemistry, histopathology, and biomarker studies of swertiamarin, a secoiridoid glycoside, prevents and protects streptozotocin-induced β-cell damage in Wistar rat pancreas.

Authors:  G Dhanavathy
Journal:  J Endocrinol Invest       Date:  2015-03-15       Impact factor: 4.256

2.  Antidiabetic and hypolipidemic activities of eburicoic acid, a triterpenoid compound from Antrodia camphorata, by regulation of Akt phosphorylation, gluconeogenesis, and PPARα in streptozotocin-induced diabetic mice.

Authors:  Cheng-Hsiu Lin; Yueh-Hsiung Kuo; Chun-Ching Shih
Journal:  RSC Adv       Date:  2018-06-05       Impact factor: 4.036

3.  Keratin Scaffolds Containing Casomorphin Stimulate Macrophage Infiltration and Accelerate Full-Thickness Cutaneous Wound Healing in Diabetic Mice.

Authors:  Marek Konop; Anna K Laskowska; Mateusz Rybka; Ewa Kłodzińska; Dorota Sulejczak; Robert A Schwartz; Joanna Czuwara
Journal:  Molecules       Date:  2021-04-27       Impact factor: 4.411

4.  The protective effects of beta-casomorphin-7 against glucose -induced renal oxidative stress in vivo and vitro.

Authors:  Wei Zhang; Jinfeng Miao; Shanshan Wang; Yuanshu Zhang
Journal:  PLoS One       Date:  2013-05-03       Impact factor: 3.240

5.  Validation of the Antidiabetic and Hypolipidemic Effects of Clitocybe nuda by Assessment of Glucose Transporter 4 and Gluconeogenesis and AMPK Phosphorylation in Streptozotocin-Induced Mice.

Authors:  Chun-Ching Shih; Mei-Hsing Chen; Cheng-Hsiu Lin
Journal:  Evid Based Complement Alternat Med       Date:  2014-02-03       Impact factor: 2.629

Review 6.  Food-Derived Opioid Peptides in Human Health: A Review.

Authors:  Akanksha Tyagi; Eric Banan-Mwine Daliri; Fred Kwami Ofosu; Su-Jung Yeon; Deog-Hwan Oh
Journal:  Int J Mol Sci       Date:  2020-11-21       Impact factor: 5.923

7.  Antidiabetic and Antihyperlipidemic Effects of Sulphurenic Acid, a Triterpenoid Compound from Antrodia camphorata, in Streptozotocin-Induced Diabetic Mice.

Authors:  Cheng-Hsiu Lin; Li-Wei Hsiao; Yueh-Hsiung Kuo; Chun-Ching Shih
Journal:  Int J Mol Sci       Date:  2019-10-02       Impact factor: 5.923

Review 8.  A1- and A2 beta-casein on health-related outcomes: a scoping review of animal studies.

Authors:  Daniela Kuellenberg de Gaudry; Szimonetta Lohner; Karin Bischoff; Christine Schmucker; Simone Hoerrlein; Christine Roeger; Lukas Schwingshackl; Joerg J Meerpohl
Journal:  Eur J Nutr       Date:  2021-06-01       Impact factor: 5.614

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.